+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Prostacyclin"

Pulmonary Arterial Hypertension Market - Global Forecast 2025-2030 - Product Thumbnail Image

Pulmonary Arterial Hypertension Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 186 Pages
  • Global
From
Pulmonary Arterial Hypertension Market Report 2025 - Product Thumbnail Image

Pulmonary Arterial Hypertension Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Calcium Channel Blocker Market Report 2025 - Product Thumbnail Image

Calcium Channel Blocker Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
VELETRI Market Report 2025 - Product Thumbnail Image

VELETRI Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Treprostinil Sodium Market Report 2025 - Product Thumbnail Image

Treprostinil Sodium Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Chronic Pulmonary Hypertension Treatment Global Market Report 2025 - Product Thumbnail Image

Chronic Pulmonary Hypertension Treatment Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
Pulmonary Arterial Hypertension - Epidemiology Forecast - 2034 - Product Thumbnail Image

Pulmonary Arterial Hypertension - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 125 Pages
  • Global
From
Pulmonary Arterial Hypertension Drugs Market Report by Drug Class, Route of Administration, End User, and Region 2025-2033 - Product Thumbnail Image

Pulmonary Arterial Hypertension Drugs Market Report by Drug Class, Route of Administration, End User, and Region 2025-2033

  • Report
  • August 2025
  • 144 Pages
  • Global
From
Pulmonary Arterial Hypertension Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Thumbnail Image

Pulmonary Arterial Hypertension Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • August 2025
  • 188 Pages
  • Global
From
Pulmonary Arterial Hypertension Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Pulmonary Arterial Hypertension Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Pulmonary Arterial Hypertension Pipeline Analysis Report 2025 - Product Thumbnail Image

Pulmonary Arterial Hypertension Pipeline Analysis Report 2025

  • Report
  • June 2025
  • 200 Pages
  • Global
From
Pulmonary Arterial Hypertension Market Report and Forecast 2025-2034 - Product Thumbnail Image

Pulmonary Arterial Hypertension Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
Pulmonary Arterial Hypertension Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Thumbnail Image

Pulmonary Arterial Hypertension Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • September 2025
  • 271 Pages
  • Global
From
Pulmonary Arterial Hypertension Market: Analysis By Drug Class, By Type, By Route of Administration, By Distribution Channel, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2028 - Product Thumbnail Image

Pulmonary Arterial Hypertension Market: Analysis By Drug Class, By Type, By Route of Administration, By Distribution Channel, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2028

  • Report
  • May 2023
  • 190 Pages
  • Global
From
Antihypertensives: Global Markets to 2023 - Product Thumbnail Image

Antihypertensives: Global Markets to 2023

  • Report
  • January 2019
  • 144 Pages
  • Global
From
Pulmonary Arterial Hypertension Market Size, Share & Trends Analysis Report by Drug Class, by Type (Branded, Generics), by Route of Administration (Oral, Intravenous/ subcutaneous, Inhalational), by Region, and Segment Forecasts, 2022-2030 - Product Thumbnail Image

Pulmonary Arterial Hypertension Market Size, Share & Trends Analysis Report by Drug Class, by Type (Branded, Generics), by Route of Administration (Oral, Intravenous/ subcutaneous, Inhalational), by Region, and Segment Forecasts, 2022-2030

  • Report
  • January 2022
  • 150 Pages
  • Global
From
Branded PAH Therapeutics Market (2023 Edition) - Analysis By Drug Class, Route of Administration, Distribution Channel, By Region, By Country: Market Insights and Forecast (2019-2029) - Product Thumbnail Image

Branded PAH Therapeutics Market (2023 Edition) - Analysis By Drug Class, Route of Administration, Distribution Channel, By Region, By Country: Market Insights and Forecast (2019-2029)

  • Report
  • November 2023
  • 250 Pages
  • Global
From
Pulmonary Arterial Hypertension Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Pulmonary Arterial Hypertension Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • January 2024
  • 250 Pages
  • Global
From
Treprostinil Palmitil Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Treprostinil Palmitil Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Orenitram Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Orenitram Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Loading Indicator

Prostacyclin is a type of cardiovascular drug used to treat a variety of conditions, including pulmonary arterial hypertension, deep vein thrombosis, and coronary artery disease. It works by inhibiting platelet aggregation and reducing the risk of blood clots. Prostacyclin is typically administered intravenously or subcutaneously, and is available in both generic and branded forms. It is also used in combination with other drugs to treat certain conditions. The prostacyclin market is highly competitive, with a number of companies offering products for the treatment of cardiovascular diseases. These companies include Actelion Pharmaceuticals, Bayer AG, GlaxoSmithKline, Merck & Co., Novartis AG, Pfizer Inc., and Sanofi. Show Less Read more